Skip to main content
. 2020 Nov 7;37(4):174–181. doi: 10.4103/JOC.JOC_45_20

Table 2.

BRAF and RAS mutations in different TBSRTC categories [N = 80]

TBSRTC No. of No mutation Mutation BRAF NRAS HRAS KRAS
Category* Cases detected detected
Cat 3 18 9 9 (50%) 1 6 1 1
Cat 4 9 3 6 (66.7%) 0 3 3 0
Cat 5 16 9 7 (43.75%) 3 4 0 0
Cat 6 27 10 17 (66.7%) 12 5 0 0
Nodal metastases 10 4 6 (55.6%) 5 1 0 0
Total 80 35 45 (56.25%) 21 19 4 1
(46.7%) (42.2%) (8.9%) (2.2%)

*cases with technically noncontributory results excluded